companydata.dkABL BIOTEC A/S: Financial statements 2020
CVR: 50811018
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -115,992 and a net result of DKK 2,455,230 compared with DKK 3,308,337 the year before. Equity amounted to DKK 26,577,060. The solvency ratio was 96.7%. The company had 1 employee in the financial year.
- Gross Profit
- -115,992 kr.
- Profit/Loss
- 2,455,230 kr.
- Equity
- 26,577,060 kr.
- Total Assets
- 27,478,747 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -116 t. | 2.5 mio. | 26.6 mio. | 1 |
| 2019 | - | -114 t. | 3.3 mio. | 24.7 mio. | 1 |
| 2018 | - | -109 t. | -2 mio. | 21.5 mio. | 1 |
| 2017 | - | -125 t. | 1.1 mio. | 24.6 mio. | 1 |
| 2016 | - | -118 t. | 796 t. | 24.5 mio. | 1 |
How creditworthy is ABL BIOTEC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ABL BIOTEC A/S has published its annual report for 2019. Gross profit came to DKK -114,364, and the net result was DKK 3,308,337.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees. In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity amounted to DKK 27,884,586.